| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Director, 10% Owner
1 company
Johnson Bankole A. serves as a Chief Medical Officer at ADIL. Across recent SEC filings that breaks down to 5 buys and 4 sells. Those positions are worth an estimated $639K at current prices.
The biggest single holding is ADIL (~$639K) as Chief Medical Officer. The recent filings there lean toward selling, a net 775,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | ADIL Adial Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 200,000 | $0.00 | - | -57.4% | -26.6% | -90.1% | |
| Apr 6, 2021 | ADIL Adial Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 150,000 | $2.50 | $375,000.00 | -21.5% | +13.1% | -26.3% | |
| Aug 20, 2020 | ADIL Adial Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 350,000 | $1.21 | $423,500.00 | -99.7% | - | - | |
| Dec 12, 2019 | ADIL Adial Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 150,000 | $1.00 | $150,000.00 | -17.7% | - | - | |
| Mar 29, 2019 | ADIL Adial Pharmaceuticals, Inc. | Chief Medical Officer | Buy | 73,100 | $3.29 | $240,609.02 | +5.7% | - | - | |
| Jul 31, 2018 | ADIL Adial Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 1,400 | $0.00 | - | New | - | - |